ABBOTT LABORATORIES (ABT)

Pharmaceutical Preparations

Latest Price

$105.70

TTM P/E

29.61

Normalized P/E

23.44

Div Yield

2.31%

Book Value

29.88

P/B Ratio

3.54

Valuation metrics

EPS: $3.72

Book value / share: $29.82

Formula: √(22.5 × EPS × BVPS)

Graham Number

$49.96

53% downside

Norm. op. income: $6.8B (median of 7yr)

Tax rate: 14%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$31.29

70% downside

Base FCF: $7.4B (median of recent 5yr)

Growth: 21%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$228.56

+116% upside

EPS: $3.72

Target P/E: 23×

Formula: EPS × P/E

P/E Fair Value

$85.56

19% downside

75.2% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	145.79M	$14.97B	8.37%	-1.11M	2026-03-31
VANGUARD CAPITAL MANAGEMENT LLC	112.95M	$11.60B	6.48%	--	2026-03-31
STATE STREET CORP	79.58M	$8.17B	4.57%	-278.3K	2026-03-31
Capital Research Global Investors	49.78M	$5.11B	2.86%	+10.61M	2026-03-31
VANGUARD PORTFOLIO MANAGEMENT LLC	47.94M	$4.92B	2.75%	--	2026-03-31
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	45.50M	$4.67B	2.61%	+32.31M	2026-03-31
GEODE CAPITAL MANAGEMENT, LLC	39.15M	$4.00B	2.25%	+741.3K	2026-03-31
Capital International Investors	37.50M	$3.85B	2.15%	-25.73M	2026-03-31
MORGAN STANLEY	30.10M	$3.09B	1.73%	-6.63M	2026-03-31
WELLINGTON MANAGEMENT GROUP LLP	27.07M	$2.78B	1.55%	+3.64M	2026-03-31